Novartis
NVS
NVS
1,089 hedge funds and large institutions have $21.2B invested in Novartis in 2019 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 356 increasing their positions, 446 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,089
Holders Change
-4
Holders Change %
-0.37%
% of All Funds
23.92%
Holding in Top 10
14
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-51.72%
% of All Funds
0.31%
New
71
Increased
356
Reduced
446
Closed
69
Calls
$162M
Puts
$154M
Net Calls
+$8.43M
Net Calls Change
-$99.5M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
$452M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
$408M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
$59.7M |
| 4 |
SC
Sculptor Capital
New York
|
$28.5M |
| 5 |
Jennison Associates
New York
|
$28.3M |
Top Sellers
| 1 |
BlackRock
New York
|
$185M |
| 2 |
Dodge & Cox
San Francisco,
California
|
$2.33B |
| 3 |
Boston Partners
Boston,
Massachusetts
|
$166M |
| 4 |
Franklin Resources
San Mateo,
California
|
$1.07B |
| 5 |
BBHC
Brown Brothers Harriman & Co
New York
|
$412M |
